Differential Diagnoses

Workup

Richalet JP, Larmignat P, Poitrine E, Letournel M, Canouï-Poitrine F. Physiological Risk Factors of Severe High Altitude Illness: A Prospective Cohort Study. Am J Respir Crit Care Med. 2011 Oct 27. [QxMD MEDLINE Link].
Luks AM, Swenson ER, Bärtsch P. Acute high-altitude sickness. Eur Respir Rev. 2017 Jan. 26 (143):[QxMD MEDLINE Link].
Villafuerte FC, Corante N. Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment. High Alt Med Biol. 2016 Jun. 17 (2):61-9. [QxMD MEDLINE Link].
Hackett PH, Oelz O. The Lake Louise consensus on the definition and quantification of altitude illness. Sutton J, Coates G, Houston C, eds. Hypoxia and Mountain Medicine. 1992. 327-30.
Berger MM, Macholz F, Lehmann L, Dankl D, Hochreiter M, Bacher B, et al. Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 m. J Appl Physiol (1985). 2017 Nov 1. 123 (5):1228-1234. [QxMD MEDLINE Link].
Rexhaj E, Rimoldi SF, Pratali L, Brenner R, Andries D, Soria R, et al. Sleep-Disordered Breathing and Vascular Function in Patients With Chronic Mountain Sickness and Healthy High-Altitude Dwellers. Chest. 2016 Apr. 149 (4):991-8. [QxMD MEDLINE Link].
Schoene RB. Unraveling the mechanism of high altitude pulmonary edema. High Alt Med Biol. 2004 Summer. 5(2):125-35. [QxMD MEDLINE Link].
Swenson ER, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA. 2002 May 1. 287(17):2228-35. [QxMD MEDLINE Link].
West JB. The physiologic basis of high-altitude diseases. Ann Intern Med. 2004 Nov 16. 141(10):789-800. [QxMD MEDLINE Link].
West JB, Colice GL, Lee YJ, et al. Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. Eur Respir J. 1995 Apr. 8(4):523-9. [QxMD MEDLINE Link].
MacInnis MJ, Koehle MS, Rupert JL. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol. 2010 Winter. 11(4):349-68. [QxMD MEDLINE Link].
He X, Wang L, Zhu L, et al. A case-control study of the genetic polymorphism of IL6 and HAPE risk in a Chinese Han population. Clin Respir J. 2018 Sep. 12 (9):2419-2425. [QxMD MEDLINE Link].
Fagenholz PJ, Gutman JA, Murray AF, et al. Evidence for increased intracranial pressure in high altitude pulmonary edema. High Alt Med Biol. 2007 Winter. 8(4):331-6. [QxMD MEDLINE Link].
Xu J, Lv L, He B, et al. Characteristics of High Altitude Pulmonary Edema in Naqu at the Altitude of 4500 m. Am J Med Sci. 2021 Aug. 362 (2):154-160. [QxMD MEDLINE Link].
Harris NS, Stephen TH, Hackett P. International high altitude pulmonary edema registry: research tools for the new millinneum. High Alt Med Biol. 2004. 5(2):221.
Rodway GW, McIntosh SE, Dow J. Mountain research and rescue on Denali: a short history from the 1980s to the present. High Alt Med Biol. 2011 Fall. 12(3):277-83. [QxMD MEDLINE Link].
Newcomb L, Sherpa C, Nickol A, Windsor J. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal. Wilderness Environ Med. 2011 Sep. 22(3):197-201. [QxMD MEDLINE Link].
Anderson PJ, Miller AD, O'Malley KA, Ceridon ML, Beck KC, Wood CM, et al. Incidence and Symptoms of High Altitude Illness in South Pole Workers: Antarctic Study of Altitude Physiology (ASAP). Clin Med Insights Circ Respir Pulm Med. 2011. 5:27-35. [QxMD MEDLINE Link]. [Full Text].
Fagenholz PJ, Gutman JA, Murray AF, et al. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High Alt Med Biol. 2007 Summer. 8(2):139-46. [QxMD MEDLINE Link].
Woods P, Alcock J. High-altitude pulmonary edema. Evol Med Public Health. 2021. 9 (1):118-119. [QxMD MEDLINE Link]. [Full Text].
Fagenholz PJ, Gutman JA, Murray AF, et al. Chest ultrasonography for the diagnosis and monitoring of high-altitude pulmonary edema. Chest. 2007 Apr. 131(4):1013-8. [QxMD MEDLINE Link].
Taber R. Protocols for the use of a portable hyperbaric chamber for the treatment of high altitude disorders. J Wilderness Med. 1990. 1:181-92.
Nieto Estrada VH, Molano Franco D, Medina RD, Gonzalez Garay AG, Martí-Carvajal AJ, Arevalo-Rodriguez I. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs. Cochrane Database Syst Rev. 2017 Jun 27. 6:CD009761. [QxMD MEDLINE Link].
Zafren K, Reeves JT, Schoene R. Treatment of high-altitude pulmonary edema by bed rest and supplemental oxygen. Wilderness Environ Med. 1996 May. 7(2):127-32. [QxMD MEDLINE Link].
Schoene RB. Fatal high altitude pulmonary edema associated with absence of the left pulmonary artery. High Alt Med Biol. 2001 Fall. 2(3):405-6. [QxMD MEDLINE Link].
Kleinsasser A, Treml B, Burtscher J, Podolsky A, Burtscher M. Oxygen availability in a HAPE-positive and a HAPE-negative woman before and during a visit to 3480 meters. Respir Physiol Neurobiol. 2020 Oct. 281:103513. [QxMD MEDLINE Link].
Bartsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991 Oct 31. 325(18):1284-9. [QxMD MEDLINE Link].
Oelz O, Maggiorini M, Ritter M, et al. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker. Int J Sports Med. 1992 Oct. 13 Suppl 1:S65-8. [QxMD MEDLINE Link].
Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med. 2002 May 23. 346(21):1631-6. [QxMD MEDLINE Link].
Clarenbach CF, Christ AL, Senn O, et al. Dexamethasone and tadalafil prevent HAPE and subclinical alterations in lung function and nocturnal oxygenation associated with pulmonary interstitial fluid accumulation. High Alt Med Biol. 2004. 4:478.
Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Böhm T, Bernheim A, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med. 2006 Oct 3. 145(7):497-506. [QxMD MEDLINE Link].
Maggiorini M, Brunner-La Rocca H-P, Bihm T, et al. Phosphodiesterase-5 inhibition and glucocorticoids prevent excessive hypoxic pulmonary vasoconstriction and high altitude pulmonary edema in susceptible subjects. High Alt Med Biol. 2004. 4:494.
Richalet JP, Gratadour P, Robach P, et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med. 2005 Feb 1. 171(3):275-81. [QxMD MEDLINE Link].
Bliss A, Mahajan S, Boehm KM. Systematic Review of the Effects of Phosphodiesterase-5 Inhibitors and Dexamethasone on High Altitude Pulmonary Edema (HAPE). Spartan Med Res J. 2019 Mar 4. 3 (3):7111. [QxMD MEDLINE Link]. [Full Text].

Media Gallery

High-altitude pulmonary edema (HAPE). Image courtesy Dr Matthew Cushing.
Hyperbaric treatment at 4250 m in a Gamow bag.
Thoracic ultrasonography: comet tail sign. Patient with acute high-altitude pulmonary edema (HAPE). Note wedge-shaped forms extending from pleural lining. In contrast, normal thoracic sonogram (below) reveals only diffuse, "snow storm" appearance. Courtesy of Dr Peter Fagenholz, et al.
Thoracic ultrasonography. Normal thoracic sonogram reveals only diffuse, "snow storm" appearance without comet tail sign. Courtesy of Dr Peter Fagenholz, et al.

of 4

Author

N Stuart Harris, MD, MFA, FACEP Chief, Division of Wilderness Medicine, Fellowship Director, MGH Wilderness Medicine Fellowship, Attending Physician, Massachusetts General Hospital; Assistant Professor, Department of Surgery, Harvard Medical School

N Stuart Harris, MD, MFA, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, Massachusetts Medical Society, International Society for Mountain Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Eddy S Lang, MDCM, CCFP(EM), CSPQ Associate Professor, Senior Researcher, Division of Emergency Medicine, Department of Family Medicine, University of Calgary Faculty of Medicine; Assistant Professor, Department of Family Medicine, McGill University Faculty of Medicine, Canada

Eddy S Lang, MDCM, CCFP(EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians, Society for Academic Emergency Medicine, Canadian Association of Emergency Physicians

Disclosure: Nothing to disclose.

Chief Editor

Joe Alcock, MD, MS Associate Professor, Department of Emergency Medicine, University of New Mexico Health Sciences Center

Joe Alcock, MD, MS is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Samuel M Keim, MD, MS Professor and Chair, Department of Emergency Medicine, University of Arizona College of Medicine

Samuel M Keim, MD, MS is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Public Health Association, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Acknowledgements

Thomas E Dietz, MD Consulting Staff, Department of Emergency Medicine, Providence Hood River Memorial Hospital

Disclosure: Nothing to disclose.

Sara W Nelson, MD Resident Physician, Harvard Affiliated Emergency Medicine Residency, Brigham and Women's Hospital and Massachusetts General Hospital

Sara W Nelson, MD is a member of the following medical societies: American College of Emergency Physicians, Emergency Medicine Residents Association, and Phi Beta Kappa

Disclosure: Nothing to disclose.